title: Short-term outcome of diabetic patients in renal replacement therapy.
abstract: BACKGROUND
  Diabetic nephropathy or diabetes-related nephropathies represents one of the most relevant causes of renal failure in recent years. This complex pathological picture becomes particularly severe as time elapses and after starting renal replacement therapy (RRT).
  
  
  METHODS
  In an attempt to investigate the evolution of the major clinical features, a retrospective study was carried out on a cohort of 76 diabetic patients on RRT. Sixty-five have been treated by haemodialysis (HD) and 11 by peritoneal dialysis (CAPD), for at least 1 year. In these patients change in modality of treatment, metabolic control, cardiovascular, and ophthalmological complications, peripheral neuropathy, state of vascular access, and intradialytic complications were surveyed at initiation and after 1 year of treatment. A modified Karnofski's score was utilized, to evaluate the degree of rehabilitation. The comparison of prevalence was evaluated, using Student's t-test for paired samples.
  
  
  RESULTS
  After 1 year, 11 patients on CAPD remained on the same type of treatment. Out of 65 patients on standard bicarbonate HD, 11 were moved to acetate free biofiltration, two to paired filtration dialysis and one to haemofiltration. A worsening in arrhythmias was recorded with an increased prevalence from 25.0 to 35.0% (n.s.), and one more patient (15 vs 16 and 19 vs 20 respectively) experienced ischaemic cardiomyopathy and cerebrovascular insufficiency. Hypertension showed a significant improvement (72 vs 42, P<0.01). Nausea and vomiting, hypotensive episodes, and muscular cramps were more frequently observed. A worsening in patient's welfare was also recorded but without statistical significance.
  
  
  CONCLUSIONS
  This clinical evaluation even if retrospective and lasting 1 year, may suggest that RRT does not per se represent a cause of the development and progression of the major complications related to diabetic disease.
authors.affiliation: Divisione di Nefrologia II e Dialisi, Azienda Ospedale, Padova, Italy.
authors.forename: G F
authors.initials: GF
authors.lastname: Romagnoli
authors.forename: D
authors.initials: D
authors.lastname: Di Landro
authors.forename: C
authors.initials: C
authors.lastname: Catalano
authors.forename: V
authors.initials: V
authors.lastname: Goepel
authors.forename: S
authors.initials: S
authors.lastname: Milan Manani
authors.forename: A M
authors.initials: AM
authors.lastname: Ruffatti
authors.forename: F
authors.initials: F
authors.lastname: Marchini
authors.forename: A
authors.initials: A
authors.lastname: Naso
mesh_terms: D000328:Adult; D000368:Aged; D002408:Catheters, Indwelling; D015331:Cohort Studies; D003920:Diabetes Mellitus / Q000178:diet therapy / Q000188:drug therapy / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000628:therapy*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D017582:Renal Replacement Therapy / Q000009:adverse effects; D012189:Retrospective Studies
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin